The RYR-1 Foundation's primary mission is to find an effective treatment or cure for RYR-1-related diseases. In service of that mission, the RYR-1 Foundation has spent approximately $1.6 million since 2014 in research funding. We look forward to building on the results of our current and prior research, with a focus on exploiting the recently developed mice that have RYR-1 mutations and muscle weakness.
The RYR-1 Foundation has a rigorous grant-review process, and we are proud of the institutions that have received funding from our organization. Please see details below.